Specialization
Multiple Sclerosis, High efficacy therapies, Personalized dosing, Pharmacokinetics
Focus of research
My research focuses on the personalization of high-efficacy therapies for relapsing-remitting multiple sclerosis (RRMS). By studying the pharmacokinetics and pharmacodynamics of various monoclonal antibodies, we aim to understand the significant variability in drug metabolism among MS patients. My clinical research is centered on the adjustment and personalization of these therapies, contributing to their value in terms of safety, treatment convenience, and healthcare efficiency.